Oncternal Therapeutics (ONCT)
(Delayed Data from NSDQ)
$8.29 USD
+0.04 (0.48%)
Updated Apr 26, 2024 03:32 PM ET
After-Market: $8.21 -0.08 (-0.97%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -2.88 |
EPS Last Quarter | -3.11 |
Last EPS Surprise | -0.65% |
ABR | 1.50 |
Earnings ESP
|
-0.09% |
---|---|
Current Year | -10.67 |
Next Year | -9.63 |
EPS (TTM) | -13.51 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.18M | 0.18M | 0.72M | 0.68M |
# of Estimates | 3 | 3 | 3 | 2 |
High Estimate | 0.20M | 0.20M | 0.80M | 0.75M |
Low Estimate | 0.15M | 0.15M | 0.60M | 0.60M |
Year ago Sales | 0.20M | 0.11M | 0.79M | 0.72M |
Year over Year Growth Est. | -12.00% | 60.00% | -8.79% | -5.73% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.88 | -2.61 | -10.67 | -9.63 |
# of Estimates | 4 | 4 | 4 | 3 |
Most Recent Consensus | -3.30 | -3.42 | -14.04 | -12.00 |
High Estimate | -2.46 | -1.23 | -5.57 | -6.63 |
Low Estimate | -3.30 | -3.42 | -14.04 | -12.00 |
Year ago EPS | -4.00 | -3.00 | -13.43 | -10.67 |
Year over Year Growth Est. | 28.00% | 13.00% | 20.55% | 9.73% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.88 | -2.61 | -10.67 | -9.63 |
7 Days Ago | -2.88 | -2.61 | -10.67 | -9.63 |
30 Days Ago | -3.09 | -3.11 | -12.03 | -11.48 |
60 Days Ago | -3.06 | -3.04 | -11.16 | -12.10 |
90 Days Ago | -3.10 | -3.06 | -11.29 | -12.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.88 | -2.33 | -9.81 | -6.63 |
Zacks Consensus Estimate | -2.88 | -2.61 | -10.67 | -9.63 |
Earnings ESP | -0.09% | 10.75% | 8.06% | 31.13% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -3.11 | -3.40 | -3.00 | -4.00 | NA |
Estimate | -3.09 | -3.00 | -3.40 | -4.20 | NA |
Difference | -0.02 | -0.40 | 0.40 | 0.20 | 0.05 |
Surprise | -0.65% | -13.33% | 11.76% | 4.76% | 0.64% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more